$1.42
0.05[3.65%]
At close: Apr 22
$1.42
0[0.00%]
After Hours: 4:31PM EDT
InflaRx
(NASDAQ:IFRX)InflaRx Stock (NASDAQ:IFRX), Analyst Ratings, Price Targets, Predictions
InflaRx NV has a consensus price target of $6.83, established from looking at the 28 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Raymond James on March 22, 2024, January 25, 2024, and November 2, 2023. With an average price target of $11.67 between HC Wainwright & Co., HC Wainwright & Co., and Raymond James, there's an implied 721.60% upside for InflaRx NV from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Raymond James
Guggenheim
LifeSci Capital
Credit Suisse
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for InflaRx
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | IFRX | Buy Now | InflaRx | $1.42 | 463.38% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 01/25/2024 | IFRX | Buy Now | InflaRx | $1.42 | 463.38% | HC Wainwright & Co. | Edward White | $9 → $8 | Maintains | Buy | Get Alert |
| 11/02/2023 | IFRX | Buy Now | InflaRx | $1.42 | 1238.03% | Raymond James | Steven Seedhouse | $21 → $19 | Maintains | Strong Buy | Get Alert |
| 09/12/2023 | IFRX | Buy Now | InflaRx | $1.42 | 533.8% | HC Wainwright & Co. | Edward White | → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/31/2023 | IFRX | Buy Now | InflaRx | $1.42 | 533.8% | HC Wainwright & Co. | Edward White | → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | IFRX | Buy Now | InflaRx | $1.42 | 533.8% | HC Wainwright & Co. | Edward White | → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | IFRX | Buy Now | InflaRx | $1.42 | 533.8% | HC Wainwright & Co. | Edward White | → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | IFRX | Buy Now | InflaRx | $1.42 | 1378.87% | Raymond James | Steven Seedhouse | $25 → $21 | Maintains | Strong Buy | Get Alert |
| 04/21/2023 | IFRX | Buy Now | InflaRx | $1.42 | 533.8% | HC Wainwright & Co. | Edward White | $10 → $9 | Maintains | Buy | Get Alert |
| 04/06/2023 | IFRX | Buy Now | InflaRx | $1.42 | 1660.56% | Raymond James | Steven Seedhouse | $8 → $25 | Maintains | Strong Buy | Get Alert |
| 04/05/2023 | IFRX | Buy Now | InflaRx | $1.42 | 463.38% | Guggenheim | Yatin Suneja | → $8 | Upgrade | Neutral → Buy | Get Alert |
| 04/05/2023 | IFRX | Buy Now | InflaRx | $1.42 | 604.23% | HC Wainwright & Co. | Edward White | $6 → $10 | Reiterates | → Buy | Get Alert |
| 04/05/2023 | IFRX | Buy Now | InflaRx | $1.42 | — | LifeSci Capital | Sam Slutsky | — | Upgrade | Market Perform → Outperform | Get Alert |
| 03/23/2023 | IFRX | Buy Now | InflaRx | $1.42 | 322.54% | HC Wainwright & Co. | Edward White | → $6 | Reiterates | → Buy | Get Alert |
| 01/06/2023 | IFRX | Buy Now | InflaRx | $1.42 | 322.54% | HC Wainwright & Co. | Edward White | $8 → $6 | Maintains | Buy | Get Alert |
| 11/10/2022 | IFRX | Buy Now | InflaRx | $1.42 | 463.38% | Raymond James | Steven Seedhouse | $7 → $8 | Maintains | Strong Buy | Get Alert |
| 08/08/2022 | IFRX | Buy Now | InflaRx | $1.42 | 463.38% | HC Wainwright & Co. | Edward White | $7 → $8 | Maintains | Buy | Get Alert |
| 05/13/2022 | IFRX | Buy Now | InflaRx | $1.42 | 40.85% | Credit Suisse | Tiago Fauth | $2.5 → $2 | Maintains | Underperform | Get Alert |
| 05/13/2022 | IFRX | Buy Now | InflaRx | $1.42 | 392.96% | Raymond James | Steven Seedhouse | $15 → $7 | Maintains | Strong Buy | Get Alert |
FAQ
What is the target price for InflaRx (IFRX)?
The latest price target for InflaRx (NASDAQ: IFRX) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $8.00 expecting IFRX to rise to within 12 months (a possible 463.38% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for InflaRx (IFRX)?
The latest analyst rating for InflaRx (NASDAQ: IFRX) was provided by HC Wainwright & Co., and InflaRx reiterated their buy rating.
When was the last upgrade for InflaRx (IFRX)?
The last upgrade for InflaRx NV happened on April 5, 2023 when Guggenheim raised their price target to $8. Guggenheim previously had a neutral for InflaRx NV.
When was the last downgrade for InflaRx (IFRX)?
There is no last downgrade for InflaRx.
When is the next analyst rating going to be posted or updated for InflaRx (IFRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of InflaRx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for InflaRx was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating InflaRx (IFRX) correct?
While ratings are subjective and will change, the latest InflaRx (IFRX) rating was a reiterated with a price target of $0.00 to $8.00. The current price InflaRx (IFRX) is trading at is $1.42, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.